 |
| |
 | | Prevention | |
- Use specialized personal protective garb and mask for protection against exposure to nerve agents.
- Consider the use of pyridostigmine bromide before nerve agent exposure.
- Consider the use of topical skin protectant before nerve agent exposure.
|
|
Use specialized personal protective garb and mask for protection against exposure to nerve agents.  |
- Ensure that personnel performing decontamination or providing medical care at a site away from the primary contamination site use chemical-resistant suits, butyl rubber gloves and boots, as well as self-contained breathing apparatus (Level B protection) or a full-face air purification device (Level C protection).
| Background | Back to top
|
Consider the use of pyridostigmine bromide before nerve agent exposure. |
- Consider beginning pyridostigmine bromide tablets, 30 mg, every 8 hours when exposure to soman is thought to be imminent.
| Background | Back to top
|
Consider the use of topical skin protectant before nerve agent exposure. |
- Consider topical SERPACWA, a 50:50 paste-like mixture of perfluoroalkylpolyether and polytetrafluoroethylene, used in conjunction with personal protective equipment.
| Background | Back to top
| | | FAQs |
|
| Christine M. Stork, PharmD, DABAT has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Elliot Rodriguez, MD, FACEP has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Jerrold B. Leikin, MD, editorial consultant, received royalties from McGraw-Hill, Taylor and Francis; editor of Toxicoterrorism (McGraw-Hill).
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott. |
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|
Nerve Agent Exposure
